LSLeslie S. Satin

Leslie S. Satin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Leslie S. Satin has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • Arthur Sherman

    National Institutes of Health

    3 shared publications
  • Craig S. Nunemaker

    Department of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens, OH 45701, USA

    3 shared publications
  • Richard Bertram

    Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia; †Department of Mathematics and Programs in Neuroscience and Molecular Biophysics, Florida State University, Tallahassee, Florida; ‡Laboratory of Biological Modeling, National Institutes of Health, Bethesda, Maryland; and §Virginia Tech, Department of Mathematics, Blacksburg, Virginia

    2 shared publications
  • Camille R. Daniel

    Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia; †Department of Mathematics and Programs in Neuroscience and Molecular Biophysics, Florida State University, Tallahassee, Florida; ‡Laboratory of Biological Modeling, National Institutes of Health, Bethesda, Maryland; and §Virginia Tech, Department of Mathematics, Blacksburg, Virginia

    1 shared publication
  • David H. Wasserman

    1 shared publication
  • F.A. Khan

    Medicine (Endocrinology), Medical College of Virginia at Virginia Commonwealth University, Richmond, VA 2398

    1 shared publication

Latest Publications

  • Glucose Modulates [Ca2+]i Oscillations in Pancreatic Islets via Ionic and Glycolytic Mechanisms

    by Craig S. Nunemaker, Richard Bertram, Arthur Sherman, Krasimira Tsaneva-Atanasova, Camille R. Daniel, Leslie S. Satin


  • Open Access

    Insulin secretion in the conscious mouse is biphasic and pulsatile

    by Craig S. Nunemaker, David H. Wasserman, Owen P. McGuinness, Ian R. Sweet, Jeanette C. Teague, Leslie S. Satin

    Islets in most species respond to increased glucose with biphasic insulin secretion, marked by a sharp first-phase peak and a slowly rising second phase. Mouse islets in vitro, however, lack a robust second phase. To date, this observation has not been extended in vivo. We thus compared insulin secretion from conscious mice with isolated mouse islets in vitro. The arterial plasma insulin response to a hyperglycemic clamp was measured in conscious mice 1 wk after surgical implantation of carotid artery and jugular vein catheters. Mice were transfused using clamps with blood from a donor mouse to maintain blood volume, allowing frequent arterial sampling. When plasma glucose in vivo was raised from ∼5 to ∼13 mM, insulin rose to a first-phase peak of 403 ± 73% above basal secretion ( n = 5), followed by a rising second phase of mean 289 ± 41%. In contrast, perifused mouse islets (∼75 islets/trial) responded with a similar first phase of 508 ± 94% ( n = 4) but a smaller and virtually flat second phase of 169 ± 9% ( n = 4, P < 0.05). Furthermore, the slope of the second-phase response differed significantly from zero in mice (2.63 ± 0.39%/min, P < 0.01), in contrast to perifused islets (0.18 ± 0.14%/min, P > 0.30). Mice also displayed pulsatile patterns in insulin concentration (period: 4.2 ± 0.4 min, n = 8). Conscious mice thus responded to increased glucose with biphasic and pulsatile insulin secretion, as in other species. The robust second phase observed in vivo suggests that the processes needed to generate second-phase insulin secretion may be abrogated by islet isolation.


  • Comparison of Metabolic Oscillations from Mouse Pancreatic Beta Cells and Islets

    by Craig S. Nunemaker, Leslie S. Satin

    Rhythmic insulin secretion from pancreatic islets is the culmination of many processes both intrinsic and extrinsic to the beta cell. We wished to examine and compare endogenous metabolic oscillations in islets and isolated single beta cells that underlie secretion. Fluorescence patterns of rhodamine 123, an indicator of mitochondrial membrane potential (ΔΩm), were analyzed for period and amplitude of oscillations using two methods: CLUSTER7 and fast Fourier transform (FFT). The period of ΔΩm oscillations was greater in islets (271±21 s, n=34) compared to dispersed beta cells (180±10 s, n=54) by FFT analysis (pp3 were reduced in beta cells (35±4%) vs islets (58±9%), and hyperpolarizing responses to the calcium channel blocker nifedipine were enhanced in beta cells (15±4%) vs islets (8±1%), suggesting that mitochondria in dispersed beta cells were less energized than those in intact islets (pm, and nifedipine response suggest that incorporation into islets provides beta cells with additional modulatory influences.


  • The Ca2+ Dynamics of Isolated Mouse β-Cells and Islets: Implications for Mathematical Models

    by Min Zhang, Paula Goforth, Richard Bertram, Arthur Sherman, Leslie Satin


  • Open Access

    Calcium-activated K+ Channels of Mouse β-cells are Controlled by Both Store and Cytoplasmic Ca2+

    by P.B. Goforth, R. Bertram, F.A. Khan, M. Zhang, A. Sherman, L.S. Satin

    A novel calcium-dependent potassium current (Kslow) that slowly activates in response to a simulated islet burst was identified recently in mouse pancreatic β-cells (Göpel, S.O., T. Kanno, S. Barg, L. Eliasson, J. Galvanovskis, E. Renström, and P. Rorsman. 1999. J. Gen. Physiol. 114:759–769). Kslow activation may help terminate the cyclic bursts of Ca2+-dependent action potentials that drive Ca2+ influx and insulin secretion in β-cells. Here, we report that when [Ca2+]i handling was disrupted by blocking Ca2+ uptake into the ER with two separate agents reported to block the sarco/endoplasmic calcium ATPase (SERCA), thapsigargin (1–5 μM) or insulin (200 nM), Kslow was transiently potentiated and then inhibited. Kslow amplitude could also be inhibited by increasing extracellular glucose concentration from 5 to 10 mM. The biphasic modulation of Kslow by SERCA blockers could not be explained by a minimal mathematical model in which [Ca2+]i is divided between two compartments, the cytosol and the ER, and Kslow activation mirrors changes in cytosolic calcium induced by the burst protocol. However, the experimental findings were reproduced by a model in which Kslow activation is mediated by a localized pool of [Ca2+] in a subspace located between the ER and the plasma membrane. In this model, the subspace [Ca2+] follows changes in cytosolic [Ca2+] but with a gradient that reflects Ca2+ efflux from the ER. Slow modulation of this gradient as the ER empties and fills may enhance the role of Kslow and [Ca2+] handling in influencing β-cell electrical activity and insulin secretion.


  • Localized Calcium Influx in Pancreatic β-Cells: Its Significance for Ca2+-Dependent Insulin Secretion from the Islets of Langerhans

    by Leslie S. Satin

    Ca2+ influx through voltage-dependent Ca2+ channels plays a crucial role in stimulus-secretion coupling in pancreatic islet β-cells. Molecular and physiologic studies have identified multiple Ca2+ channel subtypes in rodent islets and insulin-secreting cell lines. The differential targeting of Ca2+ channel subtypes to the vicinity of the insulin secretory apparatus is likely to account for their selective coupling to glucose-dependent insulin secretion. In this article, I review these studies. In addition, I discuss temporal and spatial aspects of Ca2+ signaling in β-cells, the former involving the oscillatory activation of Ca2+ channels during glucose-induced electrical bursting, and the latter involving [Ca2+]i elevation in restricted microscopic “domains”, as well as direct interactions between Ca2+ channels and secretory SNARE proteins. Finally, I review the evidence supporting a possible role for Ca2+ release from the endoplasmic reticulum in glucose-dependent insulin secretion, and evidence to support the existence of novel Ca2+ entry pathways. I also show that the β-cell has an elaborate and complex set of [Ca2+]i signaling mechanisms that are capable of generating diverse and extremely precise [Ca2+]i patterns. These signals, in turn, are exquisitely coupled in space and time to the β-cell secretory machinery to produce the precise minute-to-minute control of insulin secretion necessary for body energy homeostasis.


  • Neurotransmitters and Their Receptors in the Islets of Langerhans of the Pancreas: What Messages Do Acetylcholine, Glutamate, and GABA Transmit?

    by Leslie S. Satin, Tracie A. Kinard

    Although neurotransmitters are present in pancreatic islets of Langerhans and can be shown to alter hormone secretion, their precise physiological roles in islet function and their cellular mechanisms of action are unclear. Recent research has identified specific neurotransmitter receptor isoforms in islets that may be important physiologically, because selective receptor agonists activate islet ion channels, modify intracellular [Ca2+], and affect secretion. This article focuses on the putative roles of acetylcholine, glutamate, and GABA in islet function. It has been hypothesized that acetylcholine potentiates insulin secretion by either promoting Ca release from cellular stores, activating a store depletion-activated channel, or activating a novel Na channel. GABA and glutamate, in contrast, have been proposed to mediate a novel paracrine signaling pathway whereby α- and β-cells communicate within the islet. The evidence supporting these hypotheses will be critically evaluated.